Title: Ablation of the ATP-binding cassette transporter, Abca2 modifies response to estrogen-based therapies.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20120901
Title: Outcome, clinical prognostic factors and genetic predictors of adverse reactions of intermittent combination chemotherapy with docetaxel, estramustine phosphate and carboplatin for castration-resistant prostate cancer.
Journal: International journal of clinical oncology 20120601
Title: Docetaxel-induced fatal interstitial pneumonitis in a patient with castration-resistant prostate cancer.
Journal: Korean journal of urology 20120501
Title: Castration-resistant prostate cancer: systemic therapy in 2012.
Journal: Clinics (Sao Paulo, Brazil) 20120401
Title: Current and emerging treatment options for castration-resistant prostate cancer: a focus on immunotherapy.
Journal: Journal of clinical immunology 20120201
Title: Combination treatment with metronomic temozolomide, bevacizumab and long-acting octreotide for malignant neuroendocrine tumours.
Journal: Endocrine-related cancer 20120201
Title: Surgical castration in hormone-refractory metastatic prostate cancer patients can be an alternative for medical castration.
Journal: Advances in urology 20120101
Title: Prostate-specific membrane antigen-based therapeutics.
Journal: Advances in urology 20120101
Title: Management of high-risk localized prostate cancer.
Journal: Advances in urology 20120101
Title: Synergistic Effect of Geranylgeranyltransferase Inhibitor, GGTI, and Docetaxel on the Growth of Prostate Cancer Cells.
Journal: Prostate cancer 20120101
Title: A phase III trial of docetaxel-estramustine in high-risk localised prostate cancer: a planned analysis of response, toxicity and quality of life in the GETUG 12 trial.
Journal: European journal of cancer (Oxford, England : 1990) 20120101
Title: The Role of FoxC2 Transcription Factor in Tumor Angiogenesis.
Journal: Journal of oncology 20120101
Title: Short-term clinicopathological outcome of neoadjuvant chemohormonal therapy comprising complete androgen blockade, followed by treatment with docetaxel and estramustine phosphate before radical prostatectomy in Japanese patients with high-risk localized prostate cancer.
Journal: World journal of surgical oncology 20120101
Title: In vitro and in vivo double-enhanced suicide gene therapy mediated by generation 5 polyamidoamine dendrimers for PC-3 cell line.
Journal: World journal of surgical oncology 20120101
Title: Quality of life associated with treatment of castration-resistant prostate cancer: a review of the literature.
Journal: Cancer investigation 20120101
Title: Clinical Efficacy of TroVax in the Treatment of Progressive Castration-resistant Prostate Cancer.
Journal: Clinical Medicine Insights. Oncology 20120101
Title: Caffeic acid phenethyl ester causes p21 induction, Akt signaling reduction, and growth inhibition in PC-3 human prostate cancer cells.
Journal: PloS one 20120101
Title: Docetaxel with or without estramustine for estramustine refractory castration-resistant prostate cancer: a single institution experience.
Journal: BMC urology 20120101
Title: Mitosis phase enrichment with identification of mitotic centromere-associated kinesin as a therapeutic target in castration-resistant prostate cancer.
Journal: PloS one 20120101
Title: Pathobiological implications of the expression of EGFR, pAkt, NF-κB and MIC-1 in prostate cancer stem cells and their progenies.
Journal: PloS one 20120101
Title: Clinical Indications of C-Choline PET/CT in Prostate Cancer Patients with Biochemical Relapse.
Journal: Theranostics 20120101
Title: Redefining hormone sensitive disease in advanced prostate cancer.
Journal: Advances in urology 20120101
Title: Exploring the molecular basis of antifungal synergies using genome-wide approaches.
Journal: Frontiers in microbiology 20120101
Title: Immunotherapy of genitourinary malignancies.
Journal: Journal of oncology 20120101
Title: Modulators of prostate cancer cell proliferation and viability identified by short-hairpin RNA library screening.
Journal: PloS one 20120101
Title: Castration-resistant prostate cancer: mechanisms, targets, and treatment.
Journal: Prostate cancer 20120101
Title: Effect of angiogenesis inhibitor bevacizumab on survival in patients with cancer: a meta-analysis of the published literature.
Journal: PloS one 20120101
Title: The Interactions between Insulin and Androgens in Progression to Castrate-Resistant Prostate Cancer.
Journal: Advances in urology 20120101
Title: Functional characterization of circulating tumor cells with a prostate-cancer-specific microfluidic device.
Journal: PloS one 20120101
Title: Low-dose chemotherapy with insulin (insulin potentiation therapy) in combination with hormone therapy for treatment of castration-resistant prostate cancer.
Journal: ISRN urology 20120101
Title: Toward maximizing immunotherapy in metastatic castration-resistant prostate cancer - rationale for combinatorial approaches using chemotherapy.
Journal: Frontiers in oncology 20120101
Title: Emerging targeted therapies for castration-resistant prostate cancer.
Journal: Frontiers in endocrinology 20120101
Title: Review of salvage therapy for biochemically recurrent prostate cancer: the role of imaging and rationale for systemic salvage targeted anti-prostate-specific membrane antigen radioimmunotherapy.
Journal: Advances in urology 20120101
Title: Impact of docetaxel-based chemotherapy on quality of life of patients with castration-resistant prostate cancer: results from a prospective phase II randomized trial.
Journal: BJU international 20111201
Title: The use of estramustine phosphate in the modern management of advanced prostate cancer.
Journal: BJU international 20111201
Title: Docetaxel-based therapy with or without estramustine as first-line chemotherapy for castration-resistant prostate cancer: a meta-analysis of four randomized controlled trials.
Journal: Journal of cancer research and clinical oncology 20111201
Title: Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Journal: PLoS computational biology 20111201
Title: Comparison of ketoconazole and estramustine for treating patients with castration-resistant prostate cancer.
Journal: Korean journal of urology 20111101
Title: The epothilones: new therapeutic agents for castration-resistant prostate cancer.
Journal: The oncologist 20111001
Title: Transcription factors that mediate epithelial-mesenchymal transition lead to multidrug resistance by upregulating ABC transporters.
Journal: Cell death & disease 20110701
Title: Efficacy of alternative antiandrogen therapy for prostate cancer that relapsed after initial maximum androgen blockade.
Journal: Korean journal of urology 20110701
Title: Limited expression of cytochrome p450 17α-hydroxylase/17,20-lyase in prostate cancer cell lines.
Journal: Korean journal of urology 20110701
Title: [Oral antineoplastic agents for prostate cancer].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20110601
Title: Phase II evaluation of early oral estramustine, oral etoposide, and intravenous paclitaxel combined with hormonal therapy in patients with high-risk metastatic prostate adenocarcinoma: Southwest Oncology Group S0032.
Journal: Urology 20110501
Title: Role of androgen deprivation treatment in patients with castration-resistant prostate cancer, receiving docetaxel-based chemotherapy.
Journal: American journal of clinical oncology 20110401
Title: A phase I study of personalized peptide vaccination using 14 kinds of vaccine in combination with low-dose estramustine in HLA-A24-positive patients with castration-resistant prostate cancer.
Journal: The Prostate 20110401
Title: [Long-term disease stabilization by docetaxel plus estramustine for castration-resistant prostate cancer : report of a case].
Journal: Hinyokika kiyo. Acta urologica Japonica 20110401
Title: Castration-resistant prostate cancer: targeted therapies and individualized treatment.
Journal: The oncologist 20110301
Title: [A case of castration-refractory prostate cancer showing marked decrease of serum PSA level after zoledronic acid treatment with estramustine phosphate and prednisolone].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20110301
Title: Current treatment strategies for castration-resistant prostate cancer.
Journal: Korean journal of urology 20110301
Title: Saudi Oncology Society clinical management guidelines for prostate cancer.
Journal: Urology annals 20110301
Title: Docetaxel and epirubicin compared with docetaxel and prednisone in advanced castrate-resistant prostate cancer: a randomised phase II study.
Journal: British journal of cancer 20110215
Title: A multi-centre randomised phase III trial of Dexamethasone vs Dexamethasone and diethylstilbestrol in castration-resistant prostate cancer: immediate vs deferred Diethylstilbestrol.
Journal: British journal of cancer 20110215
Title: A phase I study of OSI-461 in combination with mitoxantrone in patients with advanced solid tumors potentially responsive to mitoxantrone.
Journal: Cancer chemotherapy and pharmacology 20110201
Title: A phase 2 study of estramustine, docetaxel, and bevacizumab in men with castrate-resistant prostate cancer: results from Cancer and Leukemia Group B Study 90006.
Journal: Cancer 20110201
Title: Spirituality and end-of-life care in disadvantaged men dying of prostate cancer.
Journal: World journal of urology 20110201
Title: The role of RANK-ligand inhibition in cancer: the story of denosumab.
Journal: The oncologist 20110201
Title: Shp2 protein tyrosine phosphatase inhibitor activity of estramustine phosphate and its triterpenoid analogs.
Journal: Bioorganic & medicinal chemistry letters 20110115
Title: Neoadjuvant docetaxel/estramustine prior to radical prostatectomy or external beam radiotherapy in high risk localized prostate cancer: a phase II trial.
Journal: Urologic oncology 20110101
Title: Prognostic factors for failure after prostatectomy.
Journal: Journal of Cancer 20110101
Title: Saddle pulmonary embolism in a cancer patient with thrombocytopenia: a treatment dilemma.
Journal: Cardiology research and practice 20110101
Title: Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer.
Journal: BMC cancer 20110101
Title: Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer.
Journal: Drug design, development and therapy 20110101
Title: The validation of the standard Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire 30 (EORTC QLQ-C30) in pre-operative patients with brain tumor in China.
Journal: BMC medical research methodology 20110101
Title: Progression of metastatic castrate-resistant prostate cancer: impact of therapeutic intervention in the post-docetaxel space.
Journal: Journal of hematology & oncology 20110101
Title: Replication stress induces micronuclei comprising of aggregated DNA double-strand breaks.
Journal: PloS one 20110101
Title: Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer.
Journal: BMC cancer 20110101
Title: Novel docetaxel-loaded nanoparticles based on poly(lactide-co-caprolactone) and poly(lactide-co-glycolide-co-caprolactone) for prostate cancer treatment: formulation, characterization, and cytotoxicity studies.
Journal: Nanoscale research letters 20110101
Title: Sipuleucel-T for therapy of asymptomatic or minimally symptomatic, castrate-refractory prostate cancer: an update and perspective among other treatments.
Journal: OncoTargets and therapy 20110101
Title: Differences in treatment patterns among patients with castration-resistant prostate cancer treated by oncologists versus urologists in a US managed care population.
Journal: Cancer management and research 20110101
Title: Fospropofol: clinical pharmacology.
Journal: Journal of anaesthesiology, clinical pharmacology 20110101
Title: Peritoneal dissemination of prostate cancer due to laparoscopic radical prostatectomy: a case report.
Journal: Journal of medical case reports 20110101
Title: Molecular targeting of prostate cancer cells by a triple drug combination down-regulates integrin driven adhesion processes, delays cell cycle progression and interferes with the cdk-cyclin axis.
Journal: BMC cancer 20110101
Title: Control of prostate cancer associated with withdrawal of a supplement containing folic acid, L-methyltetrahydrofolate and vitamin B12: a case report.
Journal: Journal of medical case reports 20110101
Title: Resistance to cancer treatment: the role of somatic genetic events and the challenges for targeted therapies.
Journal: Frontiers in pharmacology 20110101
Title: Network based consensus gene signatures for biomarker discovery in breast cancer.
Journal: PloS one 20110101
Title: Management Options in Advanced Prostate Cancer: What is the Role for Sipuleucel-T?
Journal: Clinical Medicine Insights. Oncology 20110101
Title: Bevacizumab and weekly docetaxel in patients with metastatic castrate-resistant prostate cancer previously exposed to docetaxel.
Journal: Prostate cancer 20110101
Title: An aggressive signet ring cell carcinoma of the prostate in a Japanese man.
Journal: Case reports in oncology 20110101
Title: Efficacy and safety of a modular multi-modal exercise program in prostate cancer patients with bone metastases: a randomized controlled trial.
Journal: BMC cancer 20110101
Title: The state of research into children with cancer across Europe: new policies for a new decade.
Journal: Ecancermedicalscience 20110101
Title: Survival benefit during zoledronic acid and docetaxel-based chemotherapy in metastatic hormone-refractory prostate cancer patients: an institutional report.
Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20110101
Title: Sarcomatoid carcinoma of the prostate: ductal adenocarcinoma and stromal sarcoma-like appearance: a rare association.
Journal: Case reports in urology 20110101
Title: Cell death signaling and anticancer therapy.
Journal: Frontiers in oncology 20110101
Title: A preclinical therapeutic schedule optimizing docetaxel plus estramustine administration in prostate cancer.
Journal: Anti-cancer drugs 20101101
Title: Cabazitaxel in prostate cancer: stretching a string.
Journal: Lancet (London, England) 20101002
Title: [Two cases of pellagra associated with chemotherapy of docetaxel, estramustine, dexamethasone].
Journal: Hinyokika kiyo. Acta urologica Japonica 20101001
Title: Role of radical prostatectomy for high-risk prostate cancer.
Journal: Korean journal of urology 20100901
Title: Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology.
Journal: BJU international 20100801
Title: A randomized phase II trial of personalized peptide vaccine plus low dose estramustine phosphate (EMP) versus standard dose EMP in patients with castration resistant prostate cancer.
Journal: Cancer immunology, immunotherapy : CII 20100701
Title: Safety and efficacy of docetaxel, estramustine phosphate and hydrocortisone in hormone-refractory prostate cancer patients.
Journal: International journal of urology : official journal of the Japanese Urological Association 20100701
Title: [Effect of the 5-HT3 receptor antagonist granisetron on estramustine phosphate sodium (Estracyt)-induced emesis in ferrets].
Journal: Hinyokika kiyo. Acta urologica Japonica 20100701
Title: Combination chemotherapy with weekly paclitaxel or docetaxel, carboplatin, and estramustine for hormone-refractory prostate cancer.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20100601
Title: Activity of ketoconazole after taxane-based chemotherapy in castration-resistant prostate cancer.
Journal: BJU international 20100501
Title: [Prognostic factors for estrogen therapy of relapsed prostate cancer after maximal androgen blockade (MAB)].
Journal: Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20100501
Title: Hormonal therapy for prostate cancer: current topics and future perspectives.
Journal: International journal of urology : official journal of the Japanese Urological Association 20100401
Title: [Low-dose docetaxel, estramustine and dexamethasone combination chemotherapy for hormone-refractory prostate cancer].
Journal: Hinyokika kiyo. Acta urologica Japonica 20100401
Title: Phase II study of vinorelbine and estramustine in combination with conformational radiotherapy for patients with high-risk prostate cancer.
Journal: International journal of radiation oncology, biology, physics 20100315
Title: Neoadjuvant LHRH analog plus estramustine phosphate combined with three-dimensional conformal radiotherapy for intermediate- to high-risk prostate cancer: a randomized study.
Journal: International urology and nephrology 20100301
Title: [Chemotherapy with docetaxel in prostate cancer. A case report].
Journal: Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 20100301
Title: Metastasis of genitourinary tumors to the head and neck region.
Journal: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 20100201
Title: Class III beta-tubulin expression and in vitro resistance to microtubule targeting agents.
Journal: British journal of cancer 20100119
Title: Estramustine plus docetaxel as second-line therapy in patients with hormone-refractory prostate cancer resistant to docetaxel alone.
Journal: Urologic oncology 20100101
Title: Final report on low-dose estramustine phosphate (EMP) monotherapy and very low-dose EMP therapy combined with LH-RH agonist for previously untreated advanced prostate cancer.
Journal: Aktuelle Urologie 20100101
Title: [Chemotherapy with low-dose docetaxel and estramustine phosphate in patient with liver dysfunction due to liver metastases of hormone-refractory prostate cancer : a case report].
Journal: Hinyokika kiyo. Acta urologica Japonica 20100101
Title: [Update on the use of estramustin in metastatic prostate cancer].
Journal: Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 20100101
Title: Angiogenesis inhibition in prostate cancer: current uses and future promises.
Journal: Journal of oncology 20100101
Title: A randomized phase II trial of mitoxantrone, estramustine and vinorelbine or bcl-2 modulation with 13-cis retinoic acid, interferon and paclitaxel in patients with metastatic castrate-resistant prostate cancer: ECOG 3899.
Journal: Journal of translational medicine 20100101
Title: Metronomic treatment with low-dose trofosfamide leads to a long-term remission in a patient with docetaxel-refractory advanced metastatic prostate cancer.
Journal: Case reports in medicine 20100101
Title: A novel synthetic analog of 5, 8-disubstituted quinazolines blocks mitosis and induces apoptosis of tumor cells by inhibiting microtubule polymerization.
Journal: PloS one 20100101
Title: Griseofulvin stabilizes microtubule dynamics, activates p53 and inhibits the proliferation of MCF-7 cells synergistically with vinblastine.
Journal: BMC cancer 20100101
Title: Quantitative analysis of the effect of tubulin isotype expression on sensitivity of cancer cell lines to a set of novel colchicine derivatives.
Journal: Molecular cancer 20100101
Title: Epistatic and functional interactions of catechol-o-methyltransferase (COMT) and AKT1 on neuregulin1-ErbB signaling in cell models.
Journal: PloS one 20100101
Title: Modified intention to treat reporting in randomised controlled trials: systematic review.
Journal: BMJ (Clinical research ed.) 20100101
Title: Update on options for treatment of metastatic castration-resistant prostate cancer.
Journal: OncoTargets and therapy 20100101
Title: A screen for kinetochore-microtubule interaction inhibitors identifies novel antitubulin compounds.
Journal: PloS one 20100101
Title: Angiogenesis inhibitors in the treatment of prostate cancer.
Journal: Journal of hematology & oncology 20100101
Title: Cytochrome 450 1B1 (CYP1B1) polymorphisms associated with response to docetaxel in Castration-Resistant Prostate Cancer (CRPC) patients.
Journal: BMC cancer 20100101
Title: [11C]choline-PET-guided helical tomotherapy and estramustine in a patient with pelvic-recurrent prostate cancer: local control and toxicity profile after 24 months.
Journal: Tumori 20100101
Title: Novel diagnostic biomarkers for prostate cancer.
Journal: Journal of Cancer 20100101
Title: Dendritic cell-based immunotherapy for prostate cancer.
Journal: Clinical & developmental immunology 20100101
Title: Predicting outcomes of prostate cancer immunotherapy by personalized mathematical models.
Journal: PloS one 20100101
Title: Critical appraisal of cabazitaxel in the management of advanced prostate cancer.
Journal: Clinical interventions in aging 20100101
Title: Identification of a novel prostate cancer biomarker, caveolin-1: Implications and potential clinical benefit.
Journal: Cancer management and research 20100101
Title: Enhanced sensitivity to androgen withdrawal due to overexpression of interleukin-6 in androgen-dependent human prostate cancer LNCaP cells.
Journal: British journal of cancer 20091117
Title: Open-label, clinical phase I studies of tasquinimod in patients with castration-resistant prostate cancer.
Journal: British journal of cancer 20091020
Title: Phase II trial of short-term neoadjuvant docetaxel and complete androgen blockade in high-risk prostate cancer.
Journal: British journal of cancer 20091020
Title: Single nucleotide polymorphisms of 17beta-hydroxysteroid dehydrogenase type 7 gene: mechanism of estramustine-related adverse reactions?
Journal: International journal of urology : official journal of the Japanese Urological Association 20091001
Title: Increased expression of class III beta-tubulin in castration-resistant human prostate cancer.
Journal: British journal of cancer 20090915
Title: Survival after cytotoxic chemotherapy in patients with advanced hormone-resistant prostate cancer: a phase II study.
Journal: Oncology reports 20090801
Title: Evaluation of docetaxel plus estramustine in the treatment of patients with hormone-refractory prostate cancer.
Journal: International journal of urology : official journal of the Japanese Urological Association 20090801
Title: Dasatinib inhibits the growth of prostate cancer in bone and provides additional protection from osteolysis.
Journal: British journal of cancer 20090721
Title: A phase I/II trial of fixed-dose docetaxel plus irinotecan and escalating doses of estramustine phosphate for second-line or greater treatment of selected advanced solid tumors.
Journal: Anti-cancer drugs 20090701
Title: Skeletal sequelae of cancer and cancer treatment.
Journal: Journal of cancer survivorship : research and practice 20090601
Title: Phase II trial of consolidation docetaxel and samarium-153 in patients with bone metastases from castration-resistant prostate cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090520
Title: Prostate-specific antigen progression predicts overall survival in patients with metastatic prostate cancer: data from Southwest Oncology Group Trials 9346 (Intergroup Study 0162) and 9916.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090520
Title: [Toxicity and efficacy of intermittent docetaxel chemotherapy for hormone refractory prostate cancer].
Journal: Aktuelle Urologie 20090501
Title: Combining carboplatin and etoposide in docetaxel-pretreated patients with castration-resistant prostate cancer: a prospective study evaluating also neuroendocrine features.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20090401
Title: Intermittent docetaxel therapy with estramustine for hormone-refractory prostate cancer in Japanese patients.
Journal: International journal of clinical oncology 20090401
Title: Phase III multi-institutional trial of adjuvant chemotherapy with paclitaxel, estramustine, and oral etoposide combined with long-term androgen suppression therapy and radiotherapy versus long-term androgen suppression plus radiotherapy alone for high-risk prostate cancer: preliminary toxicity analysis of RTOG 99-02.
Journal: International journal of radiation oncology, biology, physics 20090301
Title: Chemotherapeutic impact on pain and global health-related quality of life in hormone-refractory prostate cancer: Dynamically Modified Outcomes (DYNAMO) analysis of a randomized controlled trial.
Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 20090301
Title: Phase II trial of estramustine phosphate and oral etoposide in patients with hormone-refractory prostate cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20090301
Title: Combining docetaxel with estramustine: back to the future?
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090301
Title: Enhancement of the activity of phenoxodiol by cisplatin in prostate cancer cells.
Journal: British journal of cancer 20090224
Title: Change in markers of bone metabolism with chemotherapy for advanced prostate cancer: interleukin-6 response is a potential early indicator of response to therapy.
Journal: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 20090201
Title: Combination chemotherapy with docetaxel, vinorelbine and estramustine phosphate in metastatic androgen-resistant prostate cancer: a single institution experience.
Journal: Anticancer research 20090201
Title: Human xenograft models as useful tools to assess the potential of novel therapeutics in prostate cancer.
Journal: British journal of cancer 20090113
Title: A retrospective review of combination chemohormonal therapy as initial treatment for locally advanced or metastatic adenocarcinoma of the prostate.
Journal: Urologic oncology 20090101
Title: Paclitaxel, estramustine and carboplatin combination chemotherapy after initial docetaxel-based chemotherapy in castration-resistant prostate cancer.
Journal: Oncology 20090101
Title: Advantages of second line estramustine for overall survival of hormone-refractory prostate cancer (HRPC) patients.
Journal: Asian Pacific journal of cancer prevention : APJCP 20090101
Title: Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer: the MRC STAMPEDE trial.
Journal: Trials 20090101
Title: Small-cell prostate carcinoma: A retrospective analysis of five newly reported cases.
Journal: Indian journal of urology : IJU : journal of the Urological Society of India 20090101
Title: Oral chemotherapy in hormone-refractory prostate carcinoma patients unwilling to be admitted to hospital.
Journal: Urologia internationalis 20090101
Title: Phase III trial of androgen ablation with or without three cycles of systemic chemotherapy for advanced prostate cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081220
Title: Dexamethasone potentiates the antiangiogenic activity of docetaxel in castration-resistant prostate cancer.
Journal: British journal of cancer 20081209
Title: Multicenter phase 2 study of neoadjuvant paclitaxel, estramustine phosphate, and carboplatin plus androgen deprivation before radiation therapy in patients with unfavorable-risk localized prostate cancer: results of Cancer and Leukemia Group B 99811.
Journal: Cancer 20081201
Title: Prostate-specific antigen flare phenomenon with docetaxel-based chemotherapy in patients with androgen-independent prostate cancer.
Journal: BJU international 20081201
Title: Bone-targeted therapy: phase II study of strontium-89 in combination with alternating weekly chemohormonal therapies for patients with advanced androgen-independent prostate cancer.
Journal: American journal of clinical oncology 20081201
Title: Novel microtubule-targeting agents - the epothilones.
Journal: Biologics : targets & therapy 20081201
Title: Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Journal: Journal of medicinal chemistry 20081113
Title: Prospective randomized study comparing docetaxel, estramustine, and prednisone with docetaxel and prednisone in metastatic hormone-refractory prostate cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081110
Title: Docetaxel, with or without estramustine phosphate, as first-line chemotherapy for hormone-refractory prostate cancer: results of a multicentre, randomized phase II trial.
Journal: BJU international 20081101
Title: Docetaxel chemotherapy of Korean patients with hormone- refractory prostate cancer:comparative analysis between 1st-line and 2nd-line docetaxel.
Journal: Yonsei medical journal 20081031
Title: Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines.
Journal: Cancer immunology, immunotherapy : CII 20081001
Title: A phase II study of estramustine, docetaxel, and exisulind in patients with hormone- refractory prostate cancer: results of cancer and leukemia group B trial 90004.
Journal: Clinical genitourinary cancer 20080901
Title: Kinetic stabilization of microtubule dynamics by estramustine is associated with tubulin acetylation, spindle abnormalities, and mitotic arrest.
Journal: Cancer research 20080801
Title: Defining the optimal treatment strategy for localized prostate cancer patients: a survey of ongoing studies at the National Cancer Institute of Canada Clinical Trials Group.
Journal: Current oncology (Toronto, Ont.) 20080801
Title: The postchemotherapy PSA surge syndrome.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20080701
Title: Oxaliplatin plus gemcitabine as a salvage schedule for hormone-refractory prostate adenocarcinoma.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20080601
Title: [Estramustine phosphate withdrawal syndrome in relapsed prostate cancer: two case reports].
Journal: Hinyokika kiyo. Acta urologica Japonica 20080601
Title: Re: Adaptive therapy for androgen-independent prostate cancer: a randomized selection trial of four regimens.
Journal: Journal of the National Cancer Institute 20080507
Title: [Chemotherapy for prostate cancer].
Journal: Presse medicale (Paris, France : 1983) 20080501
Title: Pilot trial of adjuvant paclitaxel plus estramustine in resected high-risk prostate cancer.
Journal: Urology 20080501
Title: Circulating endothelial cells as a therapeutic marker for thalidomide in combined therapy with chemotherapy drugs in a human prostate cancer model.
Journal: BJU international 20080401
Title: The effect of combined androgen blockade on bone turnover and bone mineral density in men with prostate cancer.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080301
Title: Editorial comment on: prognostic and predictive factors in patients with androgen-independent prostate cancer treated with docetaxel and estramustine: a single institution experience.
Journal: European urology 20080201
Title: Editorial comment on: prognostic and predictive factors in patients with androgen-independent prostate cancer treated with docetaxel and estramustine: a single institution experience.
Journal: European urology 20080201
Title: Prognostic and predictive factors in patients with androgen-independent prostate cancer treated with docetaxel and estramustine: a single institution experience.
Journal: European urology 20080201
Title: Weekly docetaxel, zoledronic acid and estramustine in hormone-refractory prostate cancer (HRPC).
Journal: Investigational new drugs 20080201
Title: Response to docetaxel/carboplatin-based chemotherapy as first- and second-line therapy in patients with metastatic hormone-refractory prostate cancer.
Journal: BJU international 20080201
Title: Neoadjuvant chemohormonal therapy in poor-prognosis localized prostate cancer.
Journal: Urology 20080201
Title: Second-line chemotherapy for advanced hormone-refractory prostate cancer.
Journal: Clinical advances in hematology & oncology : H&O 20080201
Title: A phase II study investigating the re-induction of endocrine sensitivity following chemotherapy in androgen-independent prostate cancer.
Journal: British journal of cancer 20080115
Title: Docetaxel, low-dose estramustine, and doxifluridine in hormone-refractory metastatic prostate cancer.
Journal: Cancer chemotherapy and pharmacology 20080101
Title: Impact of PSA flare-up in patients with hormone-refractory prostate cancer undergoing chemotherapy.
Journal: International urology and nephrology 20080101
Title: Long-term control or possible cure? Treatment of stage D2 prostate cancer under chemotherapy using cisplatin and estramustine phosphate followed by maximal androgen blockade.
Journal: International urology and nephrology 20080101
Title: Combination chemotherapy with weekly docetaxel and estramustine for hormone refractory prostate cancer in Japanese patients.
Journal: International journal of urology : official journal of the Japanese Urological Association 20080101
Title: [Synthetic estrogens: some new pharmacological actions and mechanisms].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20080101
Title: Inhibition of androgen-independent prostate cancer cell growth is enhanced by combination therapy targeting Hedgehog and ErbB signalling.
Journal: Cancer cell international 20080101
Title: Endobronchial metastasis from prostate cancer.
Journal: International urology and nephrology 20080101
Title: Comparison of three different chemotherapy regimens containing epirubicin in hormone-refractory prostate cancer patients.
Journal: TheScientificWorldJournal 20080101
Title: Zoledronic acid increases docetaxel cytotoxicity through pMEK and Mcl-1 inhibition in a hormone-sensitive prostate carcinoma cell line.
Journal: Journal of translational medicine 20080101
Title: Novel therapies in genitourinary cancer: an update.
Journal: Journal of hematology & oncology 20080101
Title: Evolving perspectives of the role of novel agents in androgen-independent prostate cancer.
Journal: Indian journal of urology : IJU : journal of the Urological Society of India 20080101
Title: Phase II study of sequential chemotherapy with docetaxel-estramustine followed by mitoxantrone-prednisone in patients with advanced hormone-refractory prostate cancer.
Journal: British journal of cancer 20071217
Title: Are prostate-specific antigen changes valid surrogates for survival in hormone-refractory prostate cancer? A meta-analysis is needed!
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071210
Title: Long-term outcome of phase I/II clinical trial of Ad-OC-TK/VAL gene therapy for hormone-refractory metastatic prostate cancer.
Journal: Human gene therapy 20071201
Title: Docetaxel treatment in the elderly patient with hormone refractory prostate cancer.
Journal: Clinical interventions in aging 20071201
Title: American Society of Clinical Oncology endorsement of the Cancer Care Ontario Practice Guideline on nonhormonal therapy for men with metastatic hormone-refractory (castration-resistant) prostate cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071120
Title: Adaptive therapy for androgen-independent prostate cancer: a randomized selection trial of four regimens.
Journal: Journal of the National Cancer Institute 20071107
Title: Weekly administration of docetaxel in combination with estramustine and celecoxib in patients with advanced hormone-refractory prostate cancer: final results from a phase II study.
Journal: British journal of cancer 20071105
Title: Addition of estramustine to chemotherapy and survival of patients with castration-refractory prostate cancer: a meta-analysis of individual patient data.
Journal: The Lancet. Oncology 20071101
Title: Estramustine in prostate cancer: new look at an old drug.
Journal: The Lancet. Oncology 20071101
Title: [Clinical study on poor PSA response to initial endocrine therapy with MAB or estrogenic drugs for treatment of prostate cancer].
Journal: Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20071101
Title: [Prostate cancer: future strategies for chemotherapy management].
Journal: Annales d'urologie 20071001
Title: Satraplatin in the treatment of hormone-refractory metastatic prostate cancer.
Journal: Therapeutics and clinical risk management 20071001
Title: Progression after docetaxel-based chemotherapy in androgen-independent prostate cancer.
Journal: BJU international 20070901
Title: Does small-cell phenotype predict the natural history of prostate cancer? A case study in disease behavior.
Journal: Nature clinical practice. Oncology 20070901
Title: Long-term follow-up of a neoadjuvant chemohormonal taxane-based phase II trial before radical prostatectomy in patients with non-metastatic high-risk prostate cancer.
Journal: BJU international 20070801
Title: Epothilones in prostate cancer: review of clinical experience.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20070701
Title: [Prostate cancer and chemotherapy].
Journal: Bulletin du cancer 20070701
Title: Randomized phase II study of docetaxel plus estramustine and single-agent docetaxel in patients with metastatic hormone-refractory prostate cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20070601
Title: Activity of weekly paclitaxel in advanced hormone-refractory prostate cancer.
Journal: American journal of clinical oncology 20070601
Title: [Prostatic carcinoma that arose with hearing loss: a case report].
Journal: Hinyokika kiyo. Acta urologica Japonica 20070601
Title: Phase II evaluation of oral estramustine, oral etoposide, and intravenous paclitaxel in patients with hormone-sensitive prostate adenocarcinoma.
Journal: Clinical genitourinary cancer 20070601
Title: A phase I trial of docetaxel/estramustine/imatinib in patients with hormone-refractory prostate cancer.
Journal: Clinical genitourinary cancer 20070601
Title: [Mediastinal lymph nodes during the course of a metastatic prostate cancer].
Journal: Actas urologicas espanolas 20070601
Title: Phase-II study of docetaxel, estramustine phosphate, and carboplatin in patients with hormone-refractory prostate cancer.
Journal: European urology 20070501
Title: Docetaxel and beyond.
Journal: European urology 20070501
Title: Pre-clinical and clinical evaluation of estramustine, docetaxel and thalidomide combination in androgen-independent prostate cancer.
Journal: BJU international 20070501
Title: Long-term outcome of a phase II study of weekly docetaxel with a short course of estramustine and enoxaparine in hormone-resistant prostate cancer patients.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20070501
Title: [Optimal treatment for elderly high-risk prostate cancer patients].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20070301
Title: Enhanced inhibitory effect of the matrix metalloproteinase inhibitor Ro 28-2653 in combination with estramustine and etoposide on the prostate carcinoma in the rat Dunning orthotopic tumor model.
Journal: Cancer chemotherapy and pharmacology 20070201
Title: Is there a role for platinum chemotherapy in the treatment of patients with hormone-refractory prostate cancer?
Journal: Cancer 20070201
Title: Oral estramustine phosphate and oral etoposide for the treatment of hormone-refractory prostate cancer.
Journal: Hinyokika kiyo. Acta urologica Japonica 20070201
Title: New multidisciplinary prostate bone metastases clinic: first of its kind in Canada.
Journal: Current oncology (Toronto, Ont.) 20070201
Title: Potentiation of antitumour activity of docetaxel by combination with trastuzumab in a human prostate cancer xenograft model and underlying mechanisms.
Journal: British journal of cancer 20070129
Title: Current indications for chemotherapy in prostate cancer patients.
Journal: European urology 20070101
Title: A systematic review and economic model of the clinical effectiveness and cost-effectiveness of docetaxel in combination with prednisone or prednisolone for the treatment of hormone-refractory metastatic prostate cancer.
Journal: Health technology assessment (Winchester, England) 20070101
Title: Effect of zoledronic acid on metastatic hormone-refractory prostate cancer resistant to taxane, estramustine, carboplatin, and dexamethasone.
Journal: International journal of urology : official journal of the Japanese Urological Association 20070101
Title: Novel expressed sequences identified in a model of androgen independent prostate cancer.
Journal: BMC genomics 20070101
Title: The ABCA2 transporter: intracellular roles in trafficking and metabolism of LDL-derived cholesterol and sterol-related compounds.
Journal: Current drug metabolism 20070101
Title: Actual chemotherapeutical possibilities in hormone-refractory prostate cancer (HRPC) patients.
Journal: Anticancer research 20070101
Title: Response to vinorelbine with or without estramustine as second-line chemotherapy in patients with hormone-refractory prostate cancer.
Journal: Cancer journal (Sudbury, Mass.) 20070101
Title: The 5th Conference on Asian Trends in Prostate Cancer Hormone Therapy.
Journal: Asian Pacific journal of cancer prevention : APJCP 20070101
Title: Combination therapy of personalized peptide vaccination and low-dose estramustine phosphate for metastatic hormone refractory prostate cancer patients: an analysis of prognostic factors in the treatment.
Journal: Oncology research 20070101
Title: The impact of the catechol-O-methyltransferase Val158Met polymorphism on survival in the general population--the HUNT study.
Journal: BMC medical genetics 20070101
Title: A phase II trial of docetaxel and erlotinib as first-line therapy for elderly patients with androgen-independent prostate cancer.
Journal: BMC cancer 20070101
Title: Distribution of radioiodinated estramustine binding protein antibody in mice with DU-145 prostate cancer xenograft.
Journal: Anticancer research 20070101
Title: Metronomic chemotherapy dosing-schedules with estramustine and temozolomide act synergistically with anti-VEGFR-2 antibody to cause inhibition of human umbilical venous endothelial cell growth.
Journal: Acta oncologica (Stockholm, Sweden) 20070101
Title: Do general dimensions of quality of life add clinical value to symptom data?
Journal: Journal of the National Cancer Institute. Monographs 20070101
Title: The roles of beta-tubulin mutations and isotype expression in acquired drug resistance.
Journal: Cancer informatics 20070101
Title: Chemotherapy for hormone-resistant prostate cancer: Where are we today?
Journal: Indian journal of urology : IJU : journal of the Urological Society of India 20070101
Title: New therapeutic targets in the treatment of prostate cancer.
Journal: Indian journal of urology : IJU : journal of the Urological Society of India 20070101
Title: Treatment algorithm in hormone-resistant prostate cancer: Practical guidelines.
Journal: Indian journal of urology : IJU : journal of the Urological Society of India 20070101
Title: The case for early chemotherapy for the treatment of metastatic disease.
Journal: The Journal of urology 20061201
Title: Docetaxel, estramustine, and 15-month androgen deprivation for men with prostate-specific antigen progression after definitive local therapy for prostate cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20061201
Title: DNA microarrays in herbal drug research.
Journal: Evidence-based complementary and alternative medicine : eCAM 20061201
Title: Phase II study of low-dose docetaxel/estramustine in elderly patients or patients aged 18-74 years with hormone-refractory prostate cancer.
Journal: Clinical genitourinary cancer 20061201
Title: Adjuvant and neoadjuvant therapies in high risk localized prostate cancer.
Journal: Journal of experimental & clinical cancer research : CR 20061201
Title: The ATP-binding cassette transporter ABCA2 as a mediator of intracellular trafficking.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20061101
Title: Chemotherapy for hormone-refractory prostate cancer.
Journal: The Cochrane database of systematic reviews 20061018
Title: Hoosier Oncology Group randomized phase II study of docetaxel, vinorelbine, and estramustine in combination in hormone-refractory prostate cancer with pharmacogenetic survival analysis.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20061015
Title: Personalized peptide vaccines: a new therapeutic modality for cancer.
Journal: Cancer science 20061001
Title: A randomized study of docetaxel and dexamethasone with low- or high-dose estramustine for patients with advanced hormone-refractory prostate cancer.
Journal: BJU international 20060901
Title: A phase II study of weekly paclitaxel/estramustine/carboplatin in hormone-refractory prostate cancer.
Journal: Clinical genitourinary cancer 20060901
Title: Thalidomide/estramustine/paclitaxel in metastatic androgen-independent prostate cancer.
Journal: Clinical genitourinary cancer 20060901
Title: A systematic review of the effectiveness of docetaxel and mitoxantrone for the treatment of metastatic hormone-refractory prostate cancer.
Journal: British journal of cancer 20060821
Title: Phase II trial evaluating a docetaxel-capecitabine combination as treatment for hormone-refractory prostate cancer.
Journal: Cancer 20060815
Title: [Treatment strategy for advanced prostate cancer with bone metastases].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20060801
Title: A randomized comparative study of endocrine monotherapy and a combination of estramustine phosphate with the endocrine therapy in patients with untreated stage D prostate cancer.
Journal: International journal of clinical oncology 20060801
Title: High-grade astrocytoma treated concomitantly with estramustine and radiotherapy.
Journal: Journal of neuro-oncology 20060701
Title: Combination therapy using LHRH and somatostatin analogues plus dexamethasone in androgen ablation refractory prostate cancer patients with bone involvement: a bench to bedside approach.
Journal: Expert opinion on investigational drugs 20060701
Title: Dramatic decline in prostate-specific antigen by withdrawal of estramustine phosphate in hormone refractory prostate cancer.
Journal: International journal of urology : official journal of the Japanese Urological Association 20060701
Title: Quality of life and pain in advanced stage prostate cancer: results of a Southwest Oncology Group randomized trial comparing docetaxel and estramustine to mitoxantrone and prednisone.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060620
Title: Protein expression in experimental malignant glioma varies over time and is altered by radiotherapy treatment.
Journal: British journal of cancer 20060619
Title: Dose escalation of oral vinorelbine in combination with estramustine in hormone-refractory adenocarcinoma of the prostate.
Journal: Cancer 20060615
Title: Docetaxel induces apoptosis in hormone refractory prostate carcinomas during multiple treatment cycles.
Journal: British journal of cancer 20060605
Title: Current chemotherapeutic approaches for androgen-independent prostate cancer.
Journal: Current opinion in investigational drugs (London, England : 2000) 20060601
Title: Results from a pilot Phase I trial of gefitinib combined with docetaxel and estramustine in patients with hormone-refractory prostate cancer.
Journal: Cancer 20060501
Title: Changing perspectives of the role of chemotherapy in advanced prostate cancer.
Journal: The Urologic clinics of North America 20060501
Title: Evaluation of combined (177)Lu-DOTA-8-AOC-BBN (7-14)NH(2) GRP receptor-targeted radiotherapy and chemotherapy in PC-3 human prostate tumor cell xenografted SCID mice.
Journal: Cancer biotherapy & radiopharmaceuticals 20060401
Title: Weekly docetaxel/estramustine phosphate in patients with increasing serum prostate- specific antigen levels after primary treatment for prostate cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
Journal: Clinical genitourinary cancer 20060301
Title: Combination chemotherapy with estramustine phosphate, ifosfamide and cisplatin for hormone-refractory prostate cancer.
Journal: Acta medica Okayama 20060201
Title: Doxetaxel: new indication. Prostate cancer: a few more weeks.
Journal: Prescrire international 20060201
Title: A retrospective evaluation of second-line chemotherapy response in hormone-refractory prostate carcinoma: second line taxane-based therapy after first-line epothilone-B analog ixabepilone (BMS-247550) therapy.
Journal: Cancer 20060101
Title: A phase I trial of pox PSA vaccines (PROSTVAC-VF) with B7-1, ICAM-1, and LFA-3 co-stimulatory molecules (TRICOM) in patients with prostate cancer.
Journal: Journal of translational medicine 20060101
Title: Administration of zoledronic acid enhances the effects of docetaxel on growth of prostate cancer in the bone environment.
Journal: BMC cancer 20060101
Title: Profiling alternatively spliced mRNA isoforms for prostate cancer classification.
Journal: BMC bioinformatics 20060101
Title: Non-hormonal systemic therapy in men with hormone-refractory prostate cancer and metastases: a systematic review from the Cancer Care Ontario Program in Evidence-based Care's Genitourinary Cancer Disease Site Group.
Journal: BMC cancer 20060101
Title: Palliative chemotherapy with trofosfamide in advanced prostate cancer.
Journal: Anticancer research 20060101
Title: Phase I/II study of weekly docetaxel and vinblastine in the treatment of metastatic hormone-refractory prostate carcinoma.
Journal: Cancer journal (Sudbury, Mass.) 20060101
Title: Repeated massive tongue swelling due to the combined use of estramustine phosphate and angiotensin-converting enzyme inhibitor.
Journal: Journal of investigational allergology & clinical immunology 20060101
Title: Evaluation of lipophilins as determinants of tumor cell response to estramustine.
Journal: The Journal of pharmacology and experimental therapeutics 20051201
Title: Therapeutic options in androgen-independent prostate cancer: building on docetaxel.
Journal: BJU international 20051201
Title: The Val158Met polymorphism of the catechol-O-methyltransferase gene is associated with the PSA-progression-free survival in prostate cancer patients treated with estramustine phosphate.
Journal: European urology 20051101
Title: Characterization of prognostic factors and efficacy in a phase-II study with docetaxel and estramustine for advanced hormone refractory prostate cancer.
Journal: Onkologie 20051101
Title: [Prostate cancer with penile metastasis: a case report].
Journal: Hinyokika kiyo. Acta urologica Japonica 20051101
Title: Monthly paclitaxel and carboplatin with oral estramustine phosphate in patients with hormone-refractory prostate cancer.
Journal: International journal of clinical oncology 20051001
Title: [Prostate cancer: update].
Journal: Bulletin du cancer 20051001
Title: Predictive factors for skeletal complications in hormone-refractory prostate cancer patients with metastatic bone disease.
Journal: British journal of cancer 20050919
Title: High dose pulse calcitriol, docetaxel and estramustine for androgen independent prostate cancer: a phase I/II study.
Journal: The Journal of urology 20050901
Title: Matrix metalloproteinase inhibitor Ro 28-2653 in combination with estramustine: tumor-reducing effects on hormone-sensitive prostate cancer in rats.
Journal: Anti-cancer drugs 20050901
Title: Prior estrogen therapy as a predictor of response to subsequent estramustine-based chemotherapy in patients with androgen-independent prostate cancer.
Journal: Clinical prostate cancer 20050901
Title: Identification of molecular mechanisms for cellular drug resistance by combining drug activity and gene expression profiles.
Journal: British journal of cancer 20050822
Title: Epothilones and the next generation of phase III trials for prostate cancer.
Journal: BJU international 20050801
Title: The combination of estramustine, vinorelbine, and mitoxantrone in hormone-refractory prostate cancer: a Phase II feasibility study conducted by the Hellenic Cooperative Oncology Group.
Journal: Urology 20050801
Title: In vitro cytotoxic effects of imatinib in combination with anticancer drugs in human prostate cancer cell lines.
Journal: The Prostate 20050601
Title: Future directions in the treatment of androgen-independent prostate cancer.
Journal: Urology 20050601
Title: An interdisciplinary approach to treating prostate cancer.
Journal: Urology 20050601
Title: Prediction of genotoxicity of chemical compounds by statistical learning methods.
Journal: Chemical research in toxicology 20050601
Title: Multicenter randomized phase II study of two schedules of docetaxel, estramustine, and prednisone versus mitoxantrone plus prednisone in patients with metastatic hormone-refractory prostate cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050520
Title: Update in the management of patients with hormone-refractory prostate cancer.
Journal: Current opinion in urology 20050501
Title: Chemotherapy for advanced prostate cancer: results of new clinical trials and future studies.
Journal: Current oncology reports 20050501
Title: Chemotherapy agents and timing of chemotherapy in prostate cancer management.
Journal: Current urology reports 20050501
Title: The current role of chemotherapy in metastatic hormone-refractory prostate cancer.
Journal: Urology 20050501
Title: [Hormonoresistant metastatic prostate cancer: analysis of two phase III clinical studies].
Journal: Bulletin du cancer 20050501
Title: Can a rational design for metronomic chemotherapy dosing be devised?
Journal: British journal of cancer 20050425
Title: Immunological evaluation of individualized peptide vaccination with a low dose of estramustine for HLA-A24+ HRPC patients.
Journal: The Prostate 20050401
Title: Support ellagic acid therapy in patients with hormone refractory prostate cancer (HRPC) on standard chemotherapy using vinorelbine and estramustine phosphate.
Journal: European urology 20050401
Title: Synergistic inhibitory effect of high-intensity focused ultrasound combined with chemotherapy on Dunning adenocarcinoma.
Journal: BJU international 20050401
Title: Docetaxel for treatment of solid tumours: a systematic review of clinical data.
Journal: The Lancet. Oncology 20050401
Title: Which drug combination for hormone-refractory prostate cancer?
Journal: Expert opinion on pharmacotherapy 20050401
Title: Recent progress in management of advanced prostate cancer.
Journal: Oncology (Williston Park, N.Y.) 20050401
Title: [The place of estramustine in the treatment of prostate cancer].
Journal: Orvosi hetilap 20050320
Title: Sequential mitoxantrone/prednisone followed by docetaxel/estramustine in patients with hormone refractory metastatic prostate cancer: results of a phase II study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20050301
Title: Multi-institutional randomized phase II trial of the epothilone B analog ixabepilone (BMS-247550) with or without estramustine phosphate in patients with progressive castrate metastatic prostate cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050301
Title: Gene expression profiling revealed novel molecular targets of docetaxel and estramustine combination treatment in prostate cancer cells.
Journal: Molecular cancer therapeutics 20050301
Title: Docetaxel-based chemotherapy as second-line treatment for paclitaxel-based chemotherapy-resistant hormone-refractory prostate cancer: a pilot study.
Journal: Urology 20050301
Title: A phase II study of vinorelbine and estramustine in patients with hormone-resistant prostate cancer.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20050301
Title: Chemotherapy for androgen-independent prostate cancer.
Journal: World journal of urology 20050201
Title: [Chemotherapy for prostate cancer].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20050201
Title: [Treatment of androgen-independent hormone refractory prostate cancer using docetaxel].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20050201
Title: Single-nucleotide polymorphisms in the 17beta-hydroxysteroid dehydrogenase genes might predict the risk of side-effects of estramustine phosphate sodium in prostate cancer patients.
Journal: International journal of urology : official journal of the Japanese Urological Association 20050201
Title: New standards in the chemotherapy of metastatic hormone-refractory prostate cancer.
Journal: Expert review of anticancer therapy 20050201
Title: Recent docetaxel studies establish a new standard of care in hormone refractory prostate cancer.
Journal: The Canadian journal of urology 20050201
Title: Can docetaxel plus estramustine prolong survival of men with metastatic hormone-refractory prostate cancer?
Journal: Nature clinical practice. Oncology 20050201
Title: Drug insight: Use of docetaxel in prostate and urothelial cancers.
Journal: Nature clinical practice. Urology 20050201
Title: Chemotherapy for advanced prostate cancer.
Journal: The New England journal of medicine 20050113
Title: Combination of docetaxel, estramustine phosphate, and zoledronic acid in androgen-independent metastatic prostate cancer: efficacy, safety, and clinical benefit assessment.
Journal: Urology 20050101
Title: A phase I study of estramustine, weekly docetaxel, and carboplatin chemotherapy in patients with hormone-refractory prostate cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20050101
Title: Combination chemotherapy with docetaxel, estramustine and suramin for hormone refractory prostate cancer.
Journal: Urologic oncology 20050101
Title: Influence of p53 and bcl-2 on chemosensitivity in benign and malignant prostatic cell lines.
Journal: Urologic oncology 20050101
Title: Oral estramustine plus oral etoposide in the treatment of hormone refractory prostate cancer patients: a phase II study with a 5-year follow-up.
Journal: Urologic oncology 20050101
Title: Administration of estramustine in response to changes in the prostate-specific antigen and Karnofsky index in the treatment of prostate cancer.
Journal: In vivo (Athens, Greece) 20050101
Title: Prospective study of estramustine phosphate for hormone refractory prostate cancer patients following androgen deprivation therapy.
Journal: Urologia internationalis 20050101
Title: Radiation sensitizing effect of estramustine is not dependent on apoptosis.
Journal: Anticancer research 20050101
Title: Advances in prostate cancer chemotherapy: a new era begins.
Journal: CA: a cancer journal for clinicians 20050101
Title: Docetaxel in hormone-refractory metastatic prostate cancer.
Journal: Drugs 20050101
Title: Dose-finding study of weekly docetaxel plus estramustine in patients with hormone-refractory metastatic prostate cancer.
Journal: Tumori 20050101
Title: Docetaxel, estramustine and prednisone for hormone-refractory prostate cancer: a single-center experience.
Journal: Anticancer research 20050101
Title: Achieving treatment goals for hormone-refractory prostate cancer with chemotherapy.
Journal: The oncologist 20050101
Title: An evaluation of high-doses ketoconazole with hydrocortisone substitution in hormone-refractory prostate cancer.
Journal: Acta chirurgica Iugoslavica 20050101
Title: Thromboembolic events with estramustine phosphate-based chemotherapy in patients with hormone-refractory prostate carcinoma: results of a meta-analysis.
Journal: Cancer 20041215
Title: Phase II trial of estramustine and etoposide in androgen-sensitive metastatic prostate carcinoma.
Journal: American journal of clinical oncology 20041201
Title: Long-term response to combination therapy with estramustine and somatostatin analogue in a patient with androgen ablation-refractory prostate cancer.
Journal: Urology 20041201
Title: Management of patients with hormone refractory prostate cancer.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain)) 20041201
Title: Phase II study of paclitaxel and estramustine in patients with recurrent and refractory non-Hodgkin lymphoma.
Journal: Cancer 20041101
Title: Epirubicin carboplatin and 5-fluorouracil (ECarboF) chemotherapy in metastatic hormone refractory prostate cancer.
Journal: British journal of cancer 20041018
Title: Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer.
Journal: The New England journal of medicine 20041007
Title: Oral low-dose cyclophosphamide in metastatic hormone refractory prostate cancer (MHRPC).
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20041001
Title: Is there a role for chemotherapy in prostate cancer?
Journal: British journal of cancer 20040913
Title: The tyrosine kinase inhibitor ZD6474 inhibits tumour growth in an intracerebral rat glioma model.
Journal: British journal of cancer 20040913
Title: Phase II randomized trial of weekly paclitaxel with or without estramustine phosphate in progressive, metastatic, hormone-refractory prostate cancer.
Journal: Clinical prostate cancer 20040901
Title: [A clinical study of estramustine phosphate sodium for the treatment of hot flushes in men with prostate cancer].
Journal: Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20040901
Title: [Combination therapy with estramustine and docetaxel for hormone refractory prostate cancer].
Journal: Hinyokika kiyo. Acta urologica Japonica 20040801
Title: Five-year outcomes after neoadjuvant chemotherapy and conformal radiotherapy in patients with high-risk localized prostate cancer.
Journal: Urology 20040701
Title: Gene expression profiling reveals novel targets of estramustine phosphate in prostate cancer cells.
Journal: Cancer letters 20040625
Title: Immunological monitoring during combination of patient-oriented peptide vaccination and estramustine phosphate in patients with metastatic hormone refractory prostate cancer.
Journal: The Prostate 20040615
Title: Mitoxantrone resistance in a small cell lung cancer cell line is associated with ABCA2 upregulation.
Journal: British journal of cancer 20040614
Title: Quantification of disseminated tumor cells in the bloodstream of patients with hormone-refractory prostate carcinoma undergoing cytotoxic chemotherapy.
Journal: International journal of oncology 20040601
Title: Simultaneous determination of estramustine phosphate and its four metabolites in human plasma by liquid chromatography-ionspray mass spectrometry.
Journal: Biomedical chromatography : BMC 20040601
Title: [Chemotherapy of the hormone-refractory prostate cancer].
Journal: Aktuelle Urologie 20040601
Title: Identification of a novel first exon of the human ABCA2 transporter gene encoding a unique N-terminus.
Journal: Biochimica et biophysica acta 20040416
Title: Capecitabine in hormone-resistant metastatic prostatic carcinoma - a phase II trial.
Journal: British journal of cancer 20040405
Title: Novel therapeutic strategies for androgen-independent prostate cancer: an update.
Journal: Seminars in oncology 20040401
Title: Weekly administration of docetaxel in patients with hormone-refractory prostate cancer: a pilot study on Japanese patients.
Journal: Japanese journal of clinical oncology 20040301
Title: Estrogens and anti-estrogens: key mediators of prostate carcinogenesis and new therapeutic candidates.
Journal: Journal of cellular biochemistry 20040215
Title: Multicenter Phase II study of estramustine phosphate plus weekly paclitaxel in patients with androgen-independent prostate carcinoma.
Journal: Cancer 20040215
Title: Chemohormonal therapy as primary treatment for metastatic prostate cancer: a randomized study of estramustine phosphate plus luteinizing hormone-releasing hormone agonist versus flutamide plus luteinizing hormone-releasing hormone agonist.
Journal: International journal of urology : official journal of the Japanese Urological Association 20040201
Title: Feasibility of radical prostatectomy after neoadjuvant chemohormonal therapy for patients with high risk or locally advanced prostate cancer: results of a phase I/II study.
Journal: The Journal of urology 20040201
Title: [Docetaxel and prostate cancer].
Journal: Bulletin du cancer 20040201
Title: [Potentiation of focal ultrasound treatment of prostate adenocarcinoma by concomitant chemotherapy with estramustine phosphate and paclitaxel].
Journal: Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 20040201
Title: Detection of HER-2/neu-positive circulating epithelial cells in prostate cancer patients.
Journal: British journal of cancer 20040126
Title: Randomized Phase II trial assessing estramustine and vinblastine combination chemotherapy vs estramustine alone in patients with progressive hormone-escaped metastatic prostate cancer.
Journal: British journal of cancer 20040112
Title: Combination of LHRH analog with somatostatin analog and dexamethasone versus chemotherapy in hormone-refractory prostate cancer: a randomized phase II study.
Journal: Urology 20040101
Title: Phase II trial of vinorelbine and estramustine in the treatment of metastatic hormone-resistant prostate cancer.
Journal: Urologic oncology 20040101
Title: Pilot study of estramustine added to radiosurgery and radiotherapy for treatment of high grade glioma.
Journal: Journal of neuro-oncology 20040101
Title: Quality of life and emotional distress in advanced prostate cancer survivors undergoing chemotherapy.
Journal: Health and quality of life outcomes 20040101
Title: Single-agent chemotherapy with docetaxel significantly reduces PSA levels in patients with high-grade localized prostate cancers.
Journal: Urologia internationalis 20040101
Title: High efficacy of docetaxel with and without androgen deprivation and estramustine in preclinical models of advanced prostate cancer.
Journal: Anticancer research 20040101
Title: Treatment options in hormone-refractory metastatic prostate carcinoma.
Journal: Tumori 20040101
Title: Cancer and Leukemia Group B (CALGB) 90203: a randomized phase 3 study of radical prostatectomy alone versus estramustine and docetaxel before radical prostatectomy for patients with high-risk localized disease.
Journal: Urology 20031229
Title: Phase 3 randomized trial evaluating second-line hormonal therapy versus docetaxel-estramustine combination chemotherapy on progression-free survival in asymptomatic patients with a rising prostate-specific antigen level after hormonal therapy for prostate cancer: an Eastern Cooperative Oncology Group (E1899), Intergroup/Clinical Trials Support Unit study.
Journal: Urology 20031229
Title: Novel approaches to treating the asymptomatic hormone-refractory prostate cancer patient.
Journal: Urology 20031229
Title: A phase II study of estramustine, docetaxel, and carboplatin with granulocyte-colony-stimulating factor support in patients with hormone-refractory prostate carcinoma: Cancer and Leukemia Group B 99813.
Journal: Cancer 20031215
Title: The evolving role of chemotherapy and other systemic therapies for managing localized prostate cancer.
Journal: The Journal of urology 20031201
Title: [Significance of docetaxel in the chemotherapy of hormone-refractory prostate cancer].
Journal: Onkologie 20031201
Title: [Intermittent oral hormonal chemotherapy using estramustine phosphate and etoposide for the treatment of hormone-refractory prostate cancer].
Journal: Hinyokika kiyo. Acta urologica Japonica 20031201
Title: Combination chemotherapy for hormone-refractory prostate carcinoma: progress and pitfalls.
Journal: Cancer 20031115
Title: Weekly paclitaxel, estramustine phosphate, and oral etoposide in the treatment of hormone-refractory prostate carcinoma: results of a Minnie Pearl Cancer Research Network phase II trial.
Journal: Cancer 20031115
Title: Vinblastine and estramustine phosphate in metastatic renal cell carcinoma: a phase II trial of the Fox Chase Network.
Journal: Cancer 20031101
Title: Clinical experience with intravenous estramustine phosphate, paclitaxel, and carboplatin in patients with castrate, metastatic prostate adenocarcinoma.
Journal: Cancer 20031101
Title: [Chemotherapy of hormone refractory prostate carcinoma].
Journal: Der Urologe. Ausg. A 20031101
Title: Unique induction of p21(WAF1/CIP1)expression by vinorelbine in androgen-independent prostate cancer cells.
Journal: British journal of cancer 20031020
Title: Pilot study of epothilone B analog (BMS-247550) and estramustine phosphate in patients with progressive metastatic prostate cancer following castration.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20031001
Title: What next after hormonotherapy in cancer prostate?
Journal: Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 20031001
Title: Prostate cancer and bone metastases: medical treatment.
Journal: Clinical orthopaedics and related research 20031001
Title: Intermittent chemotherapy in metastatic androgen-independent prostate cancer.
Journal: British journal of cancer 20030915
Title: Weekly paclitaxel plus estramustine combination therapy in hormone-refractory prostate cancer: a pilot study.
Journal: International journal of urology : official journal of the Japanese Urological Association 20030901
Title: Enzyme-mediated precipitation of parent drugs from their phosphate prodrugs.
Journal: International journal of pharmaceutics 20030811
Title: Phase II trial of paclitaxel, estramustine, etoposide, and carboplatin in the treatment of patients with hormone-refractory prostate carcinoma.
Journal: Cancer 20030715
Title: Chemotherapy of prostate cancer: present and future.
Journal: Current urology reports 20030601
Title: [Malignant priapism as a sign of a recurrent prostate cancer. Differential diagnosis of induratio penis plastica].
Journal: Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20030601
Title: Current strategies in the management of hormone refractory prostate cancer.
Journal: Cancer treatment reviews 20030601
Title: Dose escalation study of intravenous estramustine phosphate in combination with Paclitaxel and Carboplatin in patients with advanced prostate cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20030601
Title: The combination of estramustine and mitoxantrone in hormone-refractory prostate cancer: a phase II feasibility study conducted by the Hellenic Cooperative Oncology Group.
Journal: Urology 20030601
Title: Docetaxel (taxotere) in the treatment of prostate cancer.
Journal: Expert review of anticancer therapy 20030601
Title: Characterization of the MRP4- and MRP5-mediated transport of cyclic nucleotides from intact cells.
Journal: The Journal of biological chemistry 20030516
Title: Activity of docetaxel with or without estramustine phosphate versus mitoxantrone in androgen dependent and independent human prostate cancer xenografts.
Journal: The Journal of urology 20030501
Title: Physician attitudes toward cytotoxic chemotherapy use in patients with advanced prostate carcinoma.
Journal: Cancer 20030501
Title: Neoadjuvant docetaxel and estramustine chemotherapy in high-risk/locallyadvanced prostate cancer.
Journal: Urology 20030401
Title: [Prostatic cancer in the young adult].
Journal: Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 20030401
Title: Randomized, multicenter, phase II trial of two multicomponent regimens in androgen-independent prostate cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030301
Title: Current studies with docetaxel in hormone-refractory prostate cancer: selected presentations from the 27th European Society for Medical Oncology Congress, 2002.
Journal: Clinical prostate cancer 20030301
Title: A phase II trial of docetaxel and estramustine in patients with refractory metastatic breast carcinoma.
Journal: Cancer 20030201
Title: Bisphosphonate therapy for hormone refractory prostate cancer with bone metastasis.
Journal: The Journal of urology 20030101
Title: A phase I study of paclitaxel, estramustine phosphate and vinorelbine (Pacl-E-Vin) in advanced malignancies: triple tubulin targeting.
Journal: Anti-cancer drugs 20030101
Title: Estimating survival benefit in castrate metastatic prostate cancer: decision making in proceeding to a definitive phase III trial.
Journal: Urology 20030101
Title: Role of chemotherapy in hormone-refractory prostate cancer. Old issues, recent advances and new perspectives.
Journal: Urologia internationalis 20030101
Title: High-risk localized prostate cancer: primary surgery and adjuvant therapy.
Journal: Urologic oncology 20030101
Title: Neoadjuvant therapy before radical prostatectomy in high-risk localized prostate cancer: defining appropriate endpoints.
Journal: Urologic oncology 20030101
Title: Hormone refractory advanced prostate cancer treated with estramustine and paclitaxel combination.
Journal: Anticancer research 20030101
Title: Beta class II tubulin predominates in normal and tumor breast tissues.
Journal: Breast cancer research : BCR 20030101
Title: Phase II study of vinorelbine and low-dose docetaxel in chemotherapy-naive patients with hormone-refractory prostate cancer.
Journal: Cancer journal (Sudbury, Mass.) 20030101
Title: [Cell therapy and prostate cancer].
Journal: Bulletin du cancer 20030101
Title: Docetaxel for the treatment of hormone-refractory prostate cancer.
Journal: Reviews in urology 20030101
Title: E-1899: An Eastern Cooperative Oncology Group Study Comparing Ketoconazole Plus Hydrocortisone with Docetaxel Plus Estramustine for Asymptomatic, Androgen-Independent, Nonmetastatic Prostate Cancer Patients with Rising PSA Levels.
Journal: Reviews in urology 20030101
Title: A multi-institutional pilot study of adjuvant docetaxel for patients with prostate cancer at high risk for relapse after radical prostatectomy.
Journal: Reviews in urology 20030101
Title: Docetaxel for the treatment of hormone-refractory prostate cancer.
Journal: Reviews in urology 20030101
Title: E-1899: An Eastern Cooperative Oncology Group Study Comparing Ketoconazole Plus Hydrocortisone with Docetaxel Plus Estramustine for Asymptomatic, Androgen-Independent, Nonmetastatic Prostate Cancer Patients with Rising PSA Levels.
Journal: Reviews in urology 20030101
Title: A multi-institutional pilot study of adjuvant docetaxel for patients with prostate cancer at high risk for relapse after radical prostatectomy.
Journal: Reviews in urology 20030101
Title: Combination chemotherapy with paclitaxel, estramustine and carboplatin for hormone refractory prostate cancer.
Journal: The Journal of urology 20021201
Title: Editorial: States and state transitions are all that really matter.
Journal: The Journal of urology 20021201
Title: An active regimen of weekly paclitaxel and estramustine in metastatic androgen-independent prostate cancer.
Journal: Urology 20021201
Title: Fatal respiratory failure associated with treatment of prostate cancer using docetaxel and estramustine.
Journal: Urology 20021201
Title: [Chemotherapy for prostate cancers].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20021201
Title: [Therapy for hormone-refractory prostate cancer].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20021201
Title: Pattern of somatic androgen receptor gene mutations in patients with hormone-refractory prostate cancer.
Journal: Laboratory investigation; a journal of technical methods and pathology 20021101
Title: [Hormonal chemotherapy for hormone-refractory prostate cancer].
Journal: Hinyokika kiyo. Acta urologica Japonica 20021101
Title: Combined anti-microtubule therapy: a phase II study of weekly docetaxel plus estramustine in patients with metastatic breast cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20021001
Title: Drug resistance in prostate cancer cell lines is influenced by androgen dependence and p53 status.
Journal: Urological research 20021001
Title: Penile metastasis of prostatic adenocarcinoma.
Journal: International journal of urology : official journal of the Japanese Urological Association 20021001
Title: Weekly epirubicin in patients with hormone-resistant prostate cancer.
Journal: British journal of cancer 20020923
Title: Chemotherapy for prostate cancer.
Journal: Urology 20020901
Title: Hypertriglyceridemia and pancreatitis associated with estramustine phosphate.
Journal: American journal of clinical oncology 20020801
Title: Editorial: the coming revolution in the treatment of prostate cancer patients.
Journal: Seminars in urologic oncology 20020801
Title: Chemotherapy for androgen-independent prostate cancer.
Journal: Seminars in urologic oncology 20020801
Title: Ondansetron but not granisetron affect cell volume regulation and potassium ion transport of glioma cells treated with estramustine phosphate.
Journal: Journal of cancer research and clinical oncology 20020801
Title: [Second cancer after starting treatment for prostate cancer].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20020801
Title: High activity Rhenium-186 HEDP with autologous peripheral blood stem cell rescue: a phase I study in progressive hormone refractory prostate cancer metastatic to bone.
Journal: British journal of cancer 20020605
Title: Acute estramustine-induced hypocalcemia unmasking severe vitamin D deficiency.
Journal: The American journal of medicine 20020601
Title: Effects of docetaxel on pain due to metastatic androgen-independent prostate cancer.
Journal: Current urology reports 20020601
Title: Docetaxel in the integrated management of prostate cancer. Current applications and future promise.
Journal: Oncology (Williston Park, N.Y.) 20020601
Title: The role of chemotherapy in advanced prostate cancer.
Journal: The Canadian journal of urology 20020601
Title: Estramustine phosphate combined with orchidectomy as first-line therapy in patients with prostate carcinoma. Effect of age on survival.
Journal: Cancer 20020515
Title: Estramustine phosphate enhances the effects of hyperthermia and induces the small heat shock protein HSP27 in the human prostate carcinoma cell line PC-3.
Journal: Urological research 20020501
Title: A multiinstitutional, concurrent chemoradiation trial of strontium-89, estramustine, and vinblastine for hormone refractory prostate carcinoma involving bone.
Journal: Cancer 20020315
Title: Phase II evaluation of docetaxel plus one-day oral estramustine phosphate in the treatment of patients with androgen independent prostate carcinoma.
Journal: Cancer 20020301
Title: A phase II Hoosier Oncology Group study of vinorelbine and estramustine phosphate in hormone-refractory prostate cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20020301
Title: Phase I clinical and pharmacologic trial of intravenous estramustine phosphate.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020215
Title: The flare in alkaline phosphatase activity post-orchidectomy predicts which patient may benefit from early chemotherapy in metastatic prostate cancer.
Journal: The Prostate 20020201
Title: Higher doses of mitoxantrone among men with hormone-refractory prostate carcinoma: a Cancer and Leukemia Group B study.
Journal: Cancer 20020201
Title: EMP combination chemotherapy and low-dose monotherapy in advanced prostate cancer.
Journal: Expert review of anticancer therapy 20020201
Title: In vitro and in vivo activity of LS 4477 and LS 4559, novel analogues of the tubulin binder estramustine.
Journal: European journal of cancer (Oxford, England : 1990) 20020101
Title: Controversies in chemotherapy of prostate cancer.
Journal: Frontiers of radiation therapy and oncology 20020101
Title: The antimicrotubule drug estramustine but not irradiation induces apoptosis in malignant glioma involving AKT and caspase pathways.
Journal: Journal of neuro-oncology 20020101
Title: Phase I trial of oral estramustine and 3-hr infusional paclitaxel for the treatment of hormone refractory prostate cancer.
Journal: Cancer investigation 20020101
Title: Estramustine plus a taxane for advanced prostate cancer: the new standard therapy?
Journal: Cancer investigation 20020101
Title: Mechanism of action of antitumor drugs that interact with microtubules and tubulin.
Journal: Current medicinal chemistry. Anti-cancer agents 20020101
Title: Cytotoxic treatment of aggressive prostate tumors with or without neuroendocrine elements.
Journal: Acta oncologica (Stockholm, Sweden) 20020101
Title: Regulation of Cyp1a1 induction by dioxin as a function of cell cycle phase.
Journal: The Journal of pharmacology and experimental therapeutics 20011101
Title: Differential effect of vinorelbine versus paclitaxel on ERK2 kinase activity during apoptosis in MCF-7 cells.
Journal: British journal of cancer 20011101
Title: [Clinical efficacy of leuprolide acetate and combined treatment with estramustine for advanced prostate cancer].
Journal: Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20011101
Title: [A male case of primary bilateral breast cancers during estrogen therapy for prostate cancer].
Journal: Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20011101
Title: Combination therapy in hormone-refractory prostate cancer.
Journal: Current oncology reports 20010901
Title: Modulation of endogenous beta-tubulin isotype expression as a result of human beta(III)cDNA transfection into prostate carcinoma cells.
Journal: British journal of cancer 20010901
Title: Single-agent estramustine phosphate (EMP) is active in advanced breast cancer after failure with anthracyclines and taxanes.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20010901
Title: Secondary myelodysplastic syndrome after treatment of prostate cancer with oral estramustine.
Journal: American journal of hematology 20010801
Title: Treatment of hormone refractory prostate cancer.
Journal: Seminars in urologic oncology 20010801
Title: Can chemotherapy alter the course of prostate cancer?
Journal: Seminars in urologic oncology 20010801
Title: Preclinical mechanisms of action of docetaxel and docetaxel combinations in prostate cancer.
Journal: Seminars in oncology 20010801
Title: Weekly docetaxel and estramustine in patients with hormone-refractory prostate cancer.
Journal: Seminars in oncology 20010801
Title: Docetaxel, estramustine, and short-term androgen withdrawal for patients with biochemical failure after definitive local therapy for prostate cancer.
Journal: Seminars in oncology 20010801
Title: Neoadjuvant docetaxel followed by radical prostatectomy in patients with high-risk localized prostate cancer: a preliminary report.
Journal: Seminars in oncology 20010801
Title: Docetaxel, estramustine, plus trastuzumab in patients with metastatic androgen-independent prostate cancer.
Journal: Seminars in oncology 20010801
Title: Induction of apoptosis by estramustine phosphate mediated by phosphorylation of bcl-2.
Journal: Journal of neuro-oncology 20010801
Title: Phase I trial of weekly paclitaxel plus oral estramustine phosphate in patients with hormone-refractory prostate cancer.
Journal: Urology 20010701
Title: Estramustine-related hypocalcemia in patients with prostate carcinoma and osteoblastic metastases.
Journal: Urology 20010701
Title: A Phase I/II study of weekly paclitaxel and 3 days of high dose oral estramustine in patients with hormone-refractory prostate carcinoma.
Journal: Cancer 20010601
Title: Chemotherapy in patients with prostate specific antigen-only disease after primary therapy for prostate carcinoma: a phase II trial of oral estramustine and oral etoposide.
Journal: Cancer 20010601
Title: Paclitaxel and docetaxel in prostate cancer.
Journal: Hematology/oncology clinics of North America 20010601
Title: Phase II study of docetaxel, estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: a final report of CALGB 9780. Cancer and Leukemia Group B.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010501
Title: Diverging effects of 5-HT3 receptor antagonists ondansetron and granisetron on estramustine-inhibited cellular potassium transport.
Journal: Pharmacology & toxicology 20010501
Title: Estramustine potentiates taxane in prostate and refractory breast cancers.
Journal: Oncology (Williston Park, N.Y.) 20010501
Title: The impact of docetaxel, estramustine, and low dose hydrocortisone on the quality of life of men with hormone refractory prostate cancer and their partners: a feasibility study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20010501
Title: Distribution of estramustine-binding protein during postnatal development of rat brain.
Journal: Histochemistry and cell biology 20010501
Title: Cloning and characterization of human adenosine 5'-triphosphate-binding cassette, sub-family A, transporter 2 (ABCA2).
Journal: Cancer research 20010415
Title: Neoadjuvant estramustine and etoposide followed by concurrent estramustine and definitive radiotherapy for locally advanced prostate cancer: feasibility and preliminary results.
Journal: International journal of radiation oncology, biology, physics 20010301
Title: A phase II trial of estramustine and etoposide in hormone refractory prostate cancer: A Southwest Oncology Group trial (SWOG 9407).
Journal: The Prostate 20010301
Title: The bleb formation of the extracellular pseudopodia; early evidence of microtubule depolymerization by estramustine phosphate in glioma cell; in vitro study.
Journal: Journal of neuro-oncology 20010301
Title: The Collection of Indirect and Nonmedical Direct Costs (COIN) form: a new tool for collecting the invisible costs of androgen independent prostate carcinoma.
Journal: Cancer 20010215
Title: Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial.
Journal: Lancet (London, England) 20010203
Title: Phase II trial of neoadjuvant estramustine and etoposide plus radical prostatectomy for locally advanced prostate cancer.
Journal: Urology 20010201
Title: Current status of cytotoxic chemotherapy in hormone refractory prostate cancer.
Journal: European urology 20010201
Title: Necessity of re-evaluation of estramustine phosphate sodium (EMP) as a treatment option for first-line monotherapy in advanced prostate cancer.
Journal: International journal of urology : official journal of the Japanese Urological Association 20010201
Title: Docetaxel in prostate cancer.
Journal: Anti-cancer drugs 20010201
Title: Paclitaxel, estramustine phosphate, and carboplatin in patients with advanced prostate cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010101
Title: Oral combination of cyclophosphamide, uracil plus tegafur and estramustine for hormone-refractory prostate cancer.
Journal: Oncology 20010101
Title: A reexamination of PSC 833 (Valspodar) as a cytotoxic agent and in combination with anticancer agents.
Journal: Cancer chemotherapy and pharmacology 20010101
Title: Progressing prostate carcinoma.
Journal: The oncologist 20010101
Title: Oral estramustine therapy in serum chromogranin A-positive stage D3 prostate cancer patients.
Journal: Anticancer research 20010101
Title: Treatment options in hormone-refractory prostate cancer: current and future approaches.
Journal: Drugs 20010101
Title: The treatment challenge of hormone-refractory prostate cancer.
Journal: Cancer control : journal of the Moffitt Cancer Center 20010101
Title: [Chemotherapy of prostate cancer: potential role of docetaxel].
Journal: Tumori 20010101
Title: Androgen antagonistic effect of estramustine phosphate (EMP) metabolites on wild-type and mutated androgen receptor.
Journal: Biochemical pharmacology 19980501
Title: Phase II study of estramustine, oral etoposide, and vinorelbine in hormone-refractory prostate cancer.
Journal: American journal of clinical oncology 19970801
Title: Epirubicin combined with estramustine phosphate in hormone-resistant prostate cancer: a phase II study.
Journal: British journal of cancer 19970101
Title: A comparison of the effect of diethylstilbestrol with low dose estramustine phosphate in the treatment of advanced prostatic cancer: final analysis of a phase III trial of the European Organization for Research on Treatment of Cancer.
Journal: The Journal of urology 19860901
Title: Cardiovascular side effects of diethylstilbestrol, cyproterone acetate, medroxyprogesterone acetate and estramustine phosphate used for the treatment of advanced prostatic cancer: results from European Organization for Research on Treatment of Cancer trials 30761 and 30762.
Journal: The Journal of urology 19860201
Title: Cardiovascular complications of estrogen therapy for nondisseminated prostatic carcinoma. A preliminary report from a randomized multicenter study.
Journal: Scandinavian journal of urology and nephrology 19860101
Title: Cooperative clinical trials of the National Prostatic Cancer Project: Protocol 900.
Journal: The Prostate 19840101
Title: Stricture of the anterior urethra following estrogen therapy in patients with prostatic cancer.
Journal: Urologia internationalis 19830101
Title: Cardiovascular complications in the treatment of prostatic carcinoma.
Journal: British journal of urology 19811201
Title: Cardiovascular complications to treatment of prostate cancer with estramustine phosphate (Estracyt) or conventional estrogen. A follow-up of 212 randomized patients.
Journal: Scandinavian journal of urology and nephrology. Supplementum 19800101
